Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ('we' or 'Acurx' or the 'Company'), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...
Non-pathogenic Listeria, Bacillus cereus, and Staphylococcus aureus have been detected in plant-based products tested in Switzerland. The study, published ...